Avalyn Pharma Inc. · NASDAQ:AVLN
Carroll Jill bought 277,778 Avalyn Pharma Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 1, 2026
On May 1, 2026, Carroll Jill (Director) bought 277,778 Avalyn Pharma Inc. shares at US$18.00 for US$5M, leaving 2,186,562 shares. Filed May 1, 2026 (Form 4).
- Bought
- 277,778 shares
- Price
- US$18.00
- Value
- US$5M
- Holding after
- 2,186,562 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Conversion | 1,419,298 | 1,419,298 | Indirect | |
| May 1, 2026 | Common Stock | Conversion | 489,486 | 1,908,784 | Indirect | |
| May 1, 2026 | Common Stock | Buy | 277,778 | US$18.00 | 2,186,562 | Indirect |
Source
Related
- Avalyn Pharma Inc.
- Carroll Jill
- Avalyn Pharma Inc. shareholders
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Norwest Venture Partners XV, LP · Aug 11, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D · Montanova Capital, LLC · May 8, 2026
- Schedule 13D · SR One Capital Management, LLC · May 8, 2026